{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:41:42Z","timestamp":1648759302039},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"FONDECYT","award":["1130447"],"award-info":[{"award-number":["1130447"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Chromatogr Sci"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1093\/chromsci\/bmw068","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T03:10:44Z","timestamp":1462936244000},"page":"1346-1351","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Stability-Indicating LC Methods Using Light Scattering and Photodiode Array Detection with Monolithic Column for Determination of Quinapril and Hydrochlorothiazide"],"prefix":"10.1093","volume":"54","author":[{"given":"Marta","family":"de Diego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Mennickent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Charnock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"2016090704095198000_54.8.1346.1","unstructured":"Lund W. (ed). The pharmaceutical codex, 12th ed. The Pharmaceutical Press, London, (1994), p. 277."},{"key":"2016090704095198000_54.8.1346.2","unstructured":"The United States Pharmacopeia, 35th ed. The United States Pharmacopeial Convention, Inc., Rockville, (2015), pp. 1509\u20131511."},{"key":"2016090704095198000_54.8.1346.3","unstructured":"Mc Evoy G.K. (ed). AHFS drug information. American Society of Health\u2013System Pharmacists, Bethesda, (2014), pp. 2047\u20132050."},{"key":"2016090704095198000_54.8.1346.4","doi-asserted-by":"publisher","DOI":"10.2478\/s11532-013-0396-z"},{"key":"2016090704095198000_54.8.1346.5","first-page":"99","article-title":"Influence of humidity and hydroxypropyl cellulose, hydroxypropylmethyl cellulose, glyceryl behenate or magnesium stearate on the degradation kinetics of quinapril hydrochloride in solid phase","volume":"67","author":"Stanisz","year":"2010","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"2016090704095198000_54.8.1346.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.08.007"},{"key":"2016090704095198000_54.8.1346.7","first-page":"189","article-title":"The influence of pharmaceutical excipients on quinapril hydrochloride stability","volume":"62","author":"Stanisz","year":"2005","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"2016090704095198000_54.8.1346.8","first-page":"443","article-title":"The stability of quinapril hydrochloride\u2014A mixture of amorphous and crystalline forms (QHCl-AC)\u2014In solid phase","volume":"60","author":"Stanisz","year":"2003","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"2016090704095198000_54.8.1346.9","doi-asserted-by":"publisher","DOI":"10.2174\/157341211797458005"},{"key":"2016090704095198000_54.8.1346.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2004.07.050"},{"key":"2016090704095198000_54.8.1346.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(02)00385-0"},{"key":"2016090704095198000_54.8.1346.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.11.001"},{"key":"2016090704095198000_54.8.1346.13","doi-asserted-by":"publisher","DOI":"10.1002\/jps.1130"},{"key":"2016090704095198000_54.8.1346.14","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/48.7.595"},{"key":"2016090704095198000_54.8.1346.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(00)00474-X"},{"key":"2016090704095198000_54.8.1346.16","doi-asserted-by":"publisher","DOI":"10.1093\/chrsci\/49.2.129"},{"key":"2016090704095198000_54.8.1346.17","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.13-383"},{"key":"2016090704095198000_54.8.1346.18","doi-asserted-by":"publisher","DOI":"10.1365\/s10337-009-1221-x"},{"key":"2016090704095198000_54.8.1346.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.01.059"},{"key":"2016090704095198000_54.8.1346.20","unstructured":"The United States Pharmacopeia, 35th ed. The United States Pharmacopeial Convention, Inc., Rockville, (2015), pp. 5523\u20135525."},{"key":"2016090704095198000_54.8.1346.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2011.04.012"},{"key":"2016090704095198000_54.8.1346.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.10.019"},{"key":"2016090704095198000_54.8.1346.23","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201100065"},{"key":"2016090704095198000_54.8.1346.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.02.032"},{"key":"2016090704095198000_54.8.1346.25","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201301326"},{"key":"2016090704095198000_54.8.1346.26","unstructured":"International Conference on Harmonization, ICH guideline Q2 (R1), Validation of Analytical Procedures: Text and Methodology, Step 4 Version, IFMPA, (2005)."},{"key":"2016090704095198000_54.8.1346.27","unstructured":"International Conference on Harmonization, ICH guideline Q1A(R2), Stability testing of new drug substances and products, Step 4 Version, IFMPA, (2003)."},{"key":"2016090704095198000_54.8.1346.28","doi-asserted-by":"crossref","unstructured":"Baertschi S.W. (ed). Pharmaceutical stress testing, predicting drug degradation. Taylor & Francis Group, Boca Raton, (2005), p. 142.","DOI":"10.1201\/9780849359194"},{"key":"2016090704095198000_54.8.1346.29","unstructured":"International Conference on Harmonization, ICH guideline Q1B, Photostability Testing of New Drug Substances and Products, Step 4 Version, IFMPA, (1996)."},{"key":"2016090704095198000_54.8.1346.30","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21767"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/54\/8\/1346\/7080788\/bmw068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:49:35Z","timestamp":1589662175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article-lookup\/doi\/10.1093\/chromsci\/bmw068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,16]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1093\/chromsci\/bmw068"],"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmw068","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}